Sorrento Therapeutics Inc
SRNE
Get informed when a big investor buys or sells
+ FollowMarket Cap$275.64K
Close$
Share Statistics
| Market cap | $275,641.00 |
|---|---|
| Enterprise Value | $138.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.37 |
| Beta | 0.31 |
| Outstanding Shares | 551,281,000 |
Return
| Return on Equity | 260.44% |
|---|---|
| Return on Assets | -116.97% |
| Return on Invested Capital | -187.71% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.15 |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.5 |
| Debt to Equity | -1.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$8.37 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sorrento Therapeutics Inc
CEO: Henry Ji